11th Annual Drug Discovery Leaders Summit

Oxford Global Conferences is proud to present both the 11th Annual Drug Discovery Leaders Summit, which is to be held on the 9th- 10th and its Pre-Conference Symposium on Open Innovation on the 8th June 2010 at Le Montreux Palace, Switzerland. The summit is the single most senior-level and focused event in Europe dedicated to the drug discovery and pharma market.  This meeting will also be co-located with Oxford Globals’s 2nd Annual GPCR Congress.

Over three days, the Summit will attract over 175 senior-level decision makers working in drug discovery from the UK, Europe and US’s leading pharmaceutical, biotech, academic and research institutions.  This prestigious event provides a forum for R&D and drug discovery practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.
 

In keeping with Oxford Global’s highly successful drug discovery series, an expert panel of speakers will present a full conference programme covering science, technology, strategy, data management and informatics, allowing attendees to gain an essential industry update.  The symposium will be chaired by Thomas Senderovitz, Senior Vice President Global Development, Grunenthal. Key topics include:

OPEN INNOVATION SYMPOSIUM – 8th June 2010

Defining Open Innovation, Business Models, IP and Collaboration Issues, Academia Open Innovation, Biopharma Open Innovation, Current Open Innovation Initiative and Case Studies

DRUG DISCOVERY SUMMIT – 9th-10th June 2010

R&D STRATEGIES & BUSINESS MODELS AND PHARMA/BIOTECH ALLIANCES COLLABORATIONS  –Challenges and strategies to enhance productivity in drug discovery such as open innovation, innovative business models, lean thinking and the benefits of industry and academic alliances

MEDICINAL CHEMISTRY / DRUG DESIGN – Reducing attrition in development, fragment based techniques, flow chemistry, reducing risk of toxicity, structure based discovery as well as hit to lead strategies

SCREENING TECHNIQUES & ASSAY DEVELOPMENT – Improving quality of assays, compound selection, target selection and validation, as well as cost effective lead identification Initiatives for HTS, HCS and label free as well as the potential of pluripotent stem cells

BIOMARKERS & PERSONALISED / TRANSLATIONAL MEDICINE –Translational medicine and diagnostic case studies as well as how Biomarkers facilitate early decision making in early development

BIOINFORMATICS  – In-silico data, predictive modelling, Systems Biology

BIOLOGICS – Strategies to integrate biologics into an organisation, including presentations in phage display in peptides, a panel discussion on biobetters, case study on pepducins

WHO ATTENDS?

Delegates are pre-qualified dependent on budget, responsibility and seniority.  Delegates are senior-level decision makers,
from major pharmaceutical and biotech companies based in Europe and typically include SVPs, VPs and Directors of:
Drug Discovery        Biomarkers        Medicinal Chemistry        Screening     Strategic Alliances
R&D                Screening         Enabling Technologies        Genomics    Enabling Science
Toxicology        Proteomics        Structural Biology        Bioinformatics    Assay Development
Systems Biology    Translational Medicine    Lead Generation/ Validation/ Optimisation        Biologics
Open Innovation        Technology Transfer    External Research        Business Strategy
Technology Scouting    Business Development    Strategic Alliances        Strategy & Planning

YOUR NETWORKING OPPORTUNITIES

Meet face-to-face with leading solution providers and senior-level industry peers through a series of formal and informal networking opportunities.  Using our online appointment system, you are able to view the full profiles of all solution provides before the event.  In addition you have the chance to pre-arrange one-to-one meetings with them, giving you the opportunity to discuss technologies, services and solutions that address your key business needs.  Categories of solution providers include:
Biomarkers        Imaging            Strategy & Planning        Pre Clinical Analytical Testing   
HTS / HCS        RNAi            Protein Sequencing        Microarray Technology
Protemics        Genomics        Emerging Technologies        Data Management